Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Home :  Regulatory Policy :  RegWatch : 
RegWatch:     

News & Analysis | REG•WATCH Blog | Press Room

 R    E    G    •    W    A    T    C    H 


Friday, September 30, 2005

Industry $$Helps Studies Think Positively About Drugs

The argument was originally just common sense but is now empirical: drug company studies are far more likely to give high ratings to drugs than those conducted by government. The New Standard reports as follows:
A recent study found that when pharmaceutical companies fund reports about drug trials, the medicine in question is more often given a high rating than when the reports are funded by government or nonprofit sources.... In an analysis of reports about hypertension medication conducted from 1996 to 2002, University of Washington at Seattle medical resident Veronica Yank found that drug-company-sponsored studies reported a 93 percent approval rate. Government- and academic-funded studies reported a success rates hovering around 79 percent.
Another finding that validates common sense: "that fewer than half of industry-sponsored research papers reporting positive results contained data backing up the assertions."

Posted by Robert Shull



Entries by Theme

All Themes

Enforcement

About This Blog

Rollbacks

Safety

Industry Influence

Cost-Benefit Analysis

In Congress

Publications

Consumer Issues

Environment

Public Health

In the Courts

Oversight

In the White House

Most Recent Entries for RegWatch

Occupational Risk Rule Clears White House

With Concessions to Industry, Right Whale Rule May Be Moving

In Rare Move, White House Rubber Stamped Abortion Proposal

Controversial Rule on Abortion Moving Forward

Bush Administration Backs Off SCHIP Restrictions

Bush Signs Consumer Product Safety Bill

Bush Administration Cuts Habitat for Spotted Owl

Bush Trying Last-Minute Changes to Endangered Species Act

For EPA Staff Trying to Protect the Planet, "Disappointment is Profound"

Consumer Product Bill Delivers Win for Consumers

Archived Entries for Industry Influence

August

July

June

May

April

March

February

January

December, 2007

November, 2007

October, 2007

September, 2007

August, 2007

July, 2007

June, 2007

May, 2007

April, 2007

March, 2007

February, 2007

January, 2007

December, 2006

November, 2006

October, 2006

September, 2006

August, 2006

June, 2006

May, 2006

April, 2006

March, 2006

January, 2006

December, 2005

November, 2005

October, 2005

September, 2005

August, 2005

July, 2005

June, 2005

April, 2005

March, 2005

February, 2005

January, 2005

December, 2004

November, 2004

October, 2004

September, 2004

August, 2004